نتایج جستجو برای: ptr1

تعداد نتایج: 56  

2014
Abedawn I. Khalaf Judith K. Huggan Colin J. Suckling Colin L. Gibson Kirsten Stewart Federica Giordani Michael P. Barrett Pui Ee Wong Keri L. Barrack William N. Hunter

The treatment of Human African trypanosomiasis remains a major unmet health need in sub-Saharan Africa. Approaches involving new molecular targets are important; pteridine reductase 1 (PTR1), an enzyme that reduces dihydrobiopterin in Trypanosoma spp., has been identified as a candidate target, and it has been shown previously that substituted pyrrolo[2,3-d]pyrimidines are inhibitors of PTR1 fr...

Journal: :Acta crystallographica. Section D, Biological crystallography 2004
Karen McLuskey Federica Gibellini Paulo Carvalho Mitchell A Avery William N Hunter

The structure of Leishmania major pteridine reductase (PTR1) in complex with NADPH and the inhibitor 2,4,6-triaminoquinazoline (TAQ) has been solved in a new crystal form by molecular replacement and refined to 2.6 A resolution. The inhibitor mimics a fragment, the pterin head group, of the archetypal antifolate drug methotrexate (MTX) and exploits similar chemical features to bind in the PTR1 ...

Journal: :Parasitology 1997
B Nare J Luba L W Hardy S Beverley

Leishmania and other trypanosomatid protozoa require reduced pteridines (pterins and folates) for growth, suggesting that inhibition of these pathways could be targeted for effective chemotherapy. This goal has not yet been realized, indicating that pteridine metabolism may be unusual in this lower eukaryote. We have investigated this possibility using both wild type and laboratory-selected ant...

Journal: :iranian journal of parasitology 0
f kheirandish m bandehpour a haghighi f mahboudi m mohebali n mosaffa

background : leishmaniasis is an endemic disease in 88 countries. reports on leishmania drug resistance are growing in number. the mechanism of unresponsiveness against glucantime in iranian cutaneous leishmaniasis has not yet been characterized. to begin the first step in finding an anti- leishmania chemotherapy, we prepared recombinant l. major ptr1 enzyme and characterized its activity by en...

Journal: :iranian journal of public health 0
f kheirandish m bandehpour a haghighi f mahboudi m mohebali b kazemi

background: protozoa related to trypanosome family including leishmania , synthesize enzymes to escape from drug therapy. one of them is ptr1 that its enzymatic activity is similar to dihydrofolate reductase (dhfr). dihydrofolate reductase - thymidylate synthase has a major role in dna synthesis, if it is inhibited, the result would be the death of parasite. since ptr1 activity is similar to dh...

Journal: :Molecules 2014
Freddy A Bernal Ericsson Coy-Barrera

A great number of sesquiterpenes are reported in the available literature as good antileishmanial leads. However, their mode of action at the molecular level has not been elucidated. The lack of molecular studies could be considered an impediment for studies seeking to improve sesquiterpene-based drug design. The present in silico study allows us to make important observations about the molecul...

Journal: :Molecules 2017
Flavio Di Pisa Giacomo Landi Lucia Dello Iacono Cecilia Pozzi Chiara Borsari Stefania Ferrari Matteo Santucci Nuno Santarem Anabela Cordeiro-da-Silva Carolina B Moraes Laura M Alcantara Vanessa Fontana Lucio H Freitas-Junior Sheraz Gul Maria Kuzikov Birte Behrens Ina Pöhner Rebecca C Wade Maria Paola Costi Stefano Mangani

Flavonoids have previously been identified as antiparasitic agents and pteridine reductase 1 (PTR1) inhibitors. Herein, we focus our attention on the chroman-4-one scaffold. Three chroman-4-one analogues (1-3) of previously published chromen-4-one derivatives were synthesized and biologically evaluated against parasitic enzymes (Trypanosoma brucei PTR1-TbPTR1 and Leishmania major-LmPTR1) and pa...

Journal: :The Journal of biological chemistry 2004
Amal El Fadili Christoph Kündig Gaétan Roy Marc Ouellette

The protozoan parasite Leishmania is a folate and pterin auxotroph. The main biopterin transporter (BT1) and pterin reductase (PTR1) have already been characterized in Leishmania. In this study, we have succeeded in generating a BT1 and PTR1 null mutant in the same Leishmania tarentolae strain. These cells are viable with growth properties indistinguishable from wildtype cells. However, in resp...

2013
F Kheirandish M Bandehpour N Davoudi N Mosaffa S Dawood B Kazemi A Haghighi A Khamesipour H Masjedi M Mohebali F Mahboudi

BACKGROUND Pteridine metabolic pathway is unusual features of Leishmania, which is necessary for the growth of parasite. Leishmania has evolved a complex and versatile pteridine salvage network which has the ability of scavenging a wide area of the conjugated and unconjugated pteridines especially folate and biopterin. In this study, we focus on the inhibition of ptr1 gene expression. METHODS...

Journal: :Molecular and biochemical parasitology 2001
M L Cunningham S M Beverley

Protozoan parasites of the trypanosomatid genus Leishmania are pteridine auxotrophs, and have evolved an elaborate and versatile pteridine salvage network capable of accumulating and reducing pteridines. This includes biopterin and folate transporters (BT1 and FT1), pteridine reductase (PTR1), and dihydrofolate reductase-thymidylate synthase (DHFR-TS). Notably, PTR1 is a novel alternative pteri...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید